Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$513M |
| 2 |
Medtronic
MDT
|
+$477M |
| 3 |
Apple
AAPL
|
+$403M |
| 4 |
L3Harris
LHX
|
+$334M |
| 5 |
Danaher
DHR
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$433M |
| 2 |
AbbVie
ABBV
|
+$350M |
| 3 |
LLL
L3 Technologies, Inc.
LLL
|
+$315M |
| 4 |
CoStar Group
CSGP
|
+$273M |
| 5 |
Abbott
ABT
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.77% |
| 2 | Healthcare | 16.13% |
| 3 | Financials | 12.76% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SJR
1001
DELISTED
Shaw Communications Inc.
SJR
| $7.42M | ﹤0.01% |
377,727
+3,428
| +0.9% | +$67.6K |
|
1002
Zions Bancorporation
ZION
$10B
| $7.42M | ﹤0.01% |
166,650
-36,385
| -18% | -$1.57M |
|
1003
RPM International
RPM
$13.8B
| $7.23M | ﹤0.01% |
105,053
+60,944
| +138% | +$4.04M |
|
1004
Leggett & Platt
LEG
$1.5B
| $7.18M | ﹤0.01% |
175,363
+6,914
| +4% | +$271K |
|
1005
Kinross Gold
KGC
$28.6B
| $7.05M | ﹤0.01% |
1,530,639
-171,300
| -10% | -$795K |
|
|
VIAB
1006
DELISTED
Viacom Inc. Class B
VIAB
| $7.02M | ﹤0.01% |
292,034
+65,419
| +29% | +$1.83M |
|
1007
Reinsurance Group of America
RGA
$15.7B
| $6.98M | ﹤0.01% |
43,673
+20,659
| +90% | +$3.2M |
|
1008
Harley-Davidson
HOG
$2.61B
| $6.95M | ﹤0.01% |
193,313
+43,268
| +29% | +$1.48M |
|
1009
Post Holdings
POST
$4.14B
| $6.87M | ﹤0.01% |
99,137
-63,198
| -39% | -$4.31M |
|
1010
Zscaler
ZS
$23.8B
| $6.81M | ﹤0.01% |
+144,142
| New | +$10.4M |
|
|
CUK
1011
DELISTED
Carnival PLC
CUK
| $6.8M | ﹤0.01% |
161,617
+13,508
| +9% | +$603K |
|
1012
Chemed
CHE
$6.76B
| $6.79M | ﹤0.01% |
16,254
+371
| +2% | +$151K |
|
1013
Vermilion Energy
VET
$1.62B
| $6.78M | ﹤0.01% |
406,225
+169,542
| +72% | +$2.94M |
|
1014
Hubbell
HUBB
$26.3B
| $6.76M | ﹤0.01% |
51,473
-5,834
| -10% | -$752K |
|
1015
Angi Inc
ANGI
$240M
| $6.76M | ﹤0.01% |
95,398
+15,294
| +19% | +$1.57M |
|
1016
Vanguard FTSE All-World ex-US ETF
VEU
$65.9B
| $6.65M | ﹤0.01% |
133,328
-35,198
| -21% | -$1.75M |
|
1017
B2Gold
BTG
$5.16B
| $6.63M | ﹤0.01% |
+2,042,762
| New | +$6.88M |
|
1018
Wynn Resorts
WYNN
$10.3B
| $6.59M | ﹤0.01% |
60,616
+33,839
| +126% | +$4.03M |
|
1019
Franco-Nevada
FNV
$41.4B
| $6.55M | ﹤0.01% |
71,772
-44,972
| -39% | -$4.12M |
|
1020
Franklin FTSE United Kingdom ETF
FLGB
$890M
| $6.52M | ﹤0.01% |
278,426
+6,226
| +2% | +$144K |
|
1021
Qiagen
QGEN
$8.47B
| $6.49M | ﹤0.01% |
186,837
-176,001
| -49% | -$6.77M |
|
|
PARA
1022
DELISTED
Paramount Global Class B
PARA
| $6.46M | ﹤0.01% |
160,048
+12,186
| +8% | +$570K |
|
|
CIM
1023
Chimera Investment
CIM
$1.05B
| $6.45M | ﹤0.01% |
109,847
-3,599
| -3% | -$209K |
|
1024
Roku
ROKU
$21.2B
| $6.44M | ﹤0.01% |
+63,311
| New | +$7.74M |
|
1025
VYNE Therapeutics
VYNE
$19.1M
| $6.35M | ﹤0.01% |
394
-8
| -2% | -$129K |
|
Similar funds
Janus Henderson Group's Q3 2019 Portfolio in Review
As of Q3 2019, Janus Henderson Group held 1,465 positions worth $185B, up 0.14% from $184B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Janus Henderson Group's Q3 2019 filing shows 95 new, 675 increased, 602 reduced and 67 closed positions. Its largest new stake was Medtronic: 4,571,875 shares worth $497M. The largest sale was Mastercard, an estimated $433M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2019 buy was Medtronic: 4,571,875 shares worth $497M.
- Janus Henderson Group added most to Fidelity National Information Services in Q3 2019, an estimated $513M increase.
- Janus Henderson Group's biggest Q3 2019 reduction was Mastercard, cutting an estimated $433M.
- Janus Henderson Group fully exited L3 Technologies, Inc. in Q3 2019, selling an estimated $315M.
- Janus Henderson Group's ten largest holdings make up 17% of its $185B portfolio in Q3 2019.
- Janus Henderson Group opened 95 new positions and closed 67 in Q3 2019.
- Janus Henderson Group's portfolio value rose 0.14% quarter-over-quarter to $185B.
Based on Janus Henderson Group's 13F filing for Q3 2019, filed 14 Nov 2019.